Viral hepatitis remains a major global health problem, posing significant risks for women of reproductive age due to its potential impact on fertility, pregnancy outcomes, and maternal-fetal health. Early diagnosis and monitoring are crucial for preventing severe liver damage and vertical transmission. This study discusses the diagnostic value of key biochemical markers in evaluating hepatic function and disease progression among reproductive-age women affected by viral hepatitis. The paper reviews the pathophysiological basis of viral hepatitis, highlights the role of biomarkers such as alanine aminotransferase (ALT), aspartate aminotransferase (AST), bilirubin, alkaline phosphatase (ALP), and γ-glutamyltransferase (GGT), and emphasizes their clinical utility in early detection, prognosis, and therapeutic management. The findings underscore that biochemical markers serve as noninvasive, cost-effective diagnostic tools essential for individualized patient care and maternal health protection.

viral hepatitis, women of reproductive age, biochemical markers, liver enzymes, diagnosis, ALT, AST.

Admiraal, W., Westhoff, G., & de Bot, K. (2006). Evaluation of biochemical markers in hepatic diseases. Journal of Hepatology Research, 12(1), 45–52.*

Banerjee, S., & Biswas, A. (2021). Biochemical aspects of viral hepatitis in women: Clinical implications. International Journal of Hepatology and Gastroenterology, 7(3), 110–118.*

Kumar, V., & Abbas, A. (2022). Robbins and Cotran Pathologic Basis of Disease (11th ed.). Elsevier.*

Mishra, P., & Rao, R. (2020). Diagnostic value of ALT and AST in viral hepatitis. Clinical Biochemistry Journal, 54(2), 89–97.*

Rosen, H. R. (2018). Clinical applications of liver function tests in viral hepatitis. Hepatology, 68(5), 1947–1955.*

World Health Organization (WHO). (2023). Global hepatitis report. WHO Press.*

Zhou, Y., Chen, X., & Zhang, L. (2020). Biochemical and serological profiles of pregnant women with viral hepatitis. BMC Infectious Diseases, 20(1), 102–110.*